Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) for Children and Young Adults With Hematologic Malignancies

NCT06082947 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT06082947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06082947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) for Children and Young Adults With Hematologic Malignancies
Lead sponsor
Nationwide Children's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 18, 2023
Completion date
December 1, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancy, hematopoietic stem cell transplantation